Search results
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 2 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
UBS Group Trims Amgen (NASDAQ:AMGN) Target Price to $284.00
ETF DAILY NEWS· 5 days agoAmgen (NASDAQ:AMGN – Free Report) had its price objective trimmed by UBS Group from $314.00 to $284.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently ...
What Are the Most Effective Psoriasis Therapy Options?
Verywell Health via Yahoo News· 1 day agoWith many treatment options for psoriasis, how do you know which ones are right for you? Here are...
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant...
NBC 17 Raleigh· 7 days ago...who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen achieved sustained remission from week 12 through week 52 compared to 29 percent of patients receiving placebo with a 52-week steroid taper regimen1− The safety profile in GCA was generally consistent with...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 1 day agoThese product candidates are being developed to treat patients with graft-versus-host disease, psoriatic arthritis, alpha-1-antitrypsin deficiency,...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 2 days agoIn October 2023, the FDA approved Cosentyx for treating moderate-to-severe hidradenitis suppurativa...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against...
Morningstar· 4 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ventyx Biosciences, Inc ...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 6 days agoData from the SURMOUNT-OSA studies showed that treatment with tirzepatide resulted in a mean AHI...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 3 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
AbbVie Study on Treatment for Giant Cell Arteritis Meets Primary Endpoint
Morningstar· 6 days agoBy Denny Jacob AbbVie disclosed positive top-line results from a study on upadacitinib to treat adults with giant cell arteritis, an autoimmune disease. The drugmaker said its Phase 3 study showed upadacitinib in combination with a 26-week